Healthcare

Contraceptives Market by Product [Drugs (oral contraceptives, injectable contraceptives, topical contraceptives) Devices (condoms, IUDs, diaphragms, sponges, patches, implants, vaginal rings)], by Age Group (Age 15-24, Age 25-34, Age 35-44 and Above 44), by Education (Less Than High School, High School Graduate, College Graduate and Other College Degrees) and End-User (Household, Hospitals and Clinics) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • ALL22979
  • 155 Pages
  • September 2016
  • Healthcare

Contraception is the deliberate use of artificial methods to prevent pregnancy by interfering with the normal process of fertilization, ovulation, and implantation. The most common form of contraception, popularly known as fertility control or birth control, is a barrier method. It is available in two major forms in the market, namely, contraceptive drugs and devices. Contraceptive drugs include oral (pills), topical, and injectable contraceptives. Whereas, contraceptive devices include condom, Intrauterine devices (IUD), vaginal ring, implant, patch, diaphragms, sponges, and others. The major form of artificial contraception is the barrier method, especially condoms.

The world contraceptives market is expected to garner $43,812 million by 2022 from $28,175 million in 2015, registering a CAGR of 6.4% from 2016 to 2022. Increase in focus to prevent unwanted pregnancies, the incidence of STIs, and technological advancements in contraceptive methods majorly drive the market. Other birth control factors, such as family planning to improve the quality of life for both women and children and growth in adoption of modern contraceptives to control population have contributed majorly to the market growth. However, health risks associated with contraceptives, lack of social acceptance, and rise in prevalence of infertility among women hamper the Contraceptive market growth.

The world contraceptives market is segmented based on product, age group, education, end user, and geography. Based on product, the market is further segmented into contraceptive drugs and devices. Contraceptive drugs are further categorized into oral pills, topical, and injectable contraceptives. Among these, oral pills dominate the overall contraceptive drugs market, owing to their high success rate and increase in use as emergency contraceptive pills, also known as “morning pill”. In addition, contraceptive devices are further categorized into condom, IUD, vaginal ring, implant, patch, sponges, diaphragms, and others. Male condoms dominate the overall contraceptive device market due to the associated advantages such as cost-effective, fewer side effects, and ease of use.

Contraceptive market is further categorized by various age groups-15-24, 25-34, 35-44 and above 44 years, depending upon the usage and revenue generated by these age groups. On the basis of education the contraceptive market is further categorized into less than high school, high school graduate, college graduate, and other college degrees. Based on end user, the contraceptive market is segmented into household, hospitals, and, clinics. The world contraceptive market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA. These regions are further categorized into their respective countries. In 2015, North America accounted for the largest share in the contraceptive market due to factors, such as product innovations, large number of public awareness programs, and growth in incidence of unwanted pregnancies among teenagers. U.S. majorly contributes for the remarkable growth in North America especially due to the large consumer base for advanced contraception. In addition, the Asia-Pacific region is expected to offer lucrative opportunities to market players, due to increase in focus of key players to expand in the emerging economies, improvement of healthcare infrastructure, and growth in population in populace countries such as China and India.

Market players have adopted product launch and acquisition as their key strategies to sustain the intense competition in the contraceptives market. For instance, in May 2016, Allergan launched levonorgestrel-releasing intrauterine system (LILETTA) 52 mg, a hormone-releasing system placed in woman's uterus to prevent pregnancy for up to 3 years with effectiveness of more than 99%. Moreover, Actavis plc acquired Allergan, Inc. (U.S.), a pharmaceutical company to expand its product portfolio of women’s health and provide a robust platform for future product development.

KEY MARKET BENEFITS

  • This report provides the quantitative analysis of the current market and estimations for the period of 2014-2022 to identify the prevailing market opportunities.
  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the world contraceptives market.
  • The market is analyzed based on various regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided in the report.
  • In-depth analyses of current research and developments within contraceptives market are provided along with key market dynamic factors to understand the market dynamics.
  • Key market players in the market are profiled in this report along with detailed analysis of their strategies.

KEY MARKET SEGMENTS:

The world contraceptives market is segmented into product, age group, education, end user, and geography.

By Product

  • Drugs
    • Oral Contraceptive Pills
    • Injectable Contraceptives
    • Topical Contraceptives
  • Devices
    • Condoms
      • Female Condoms
      • Male Condoms
    • Intrauterine devices (IUDs)
      • Hormonal IUDs
      • Copper IUDs
  • Diaphragms
  • Sponges
  • Patches
  • Implants
  • Vaginal Rings
  • Others

AGE GROUP

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

BY END USER

  • Less than high school
  • High school graduate
  • College graduate
  • Other college degrees

By End User

  • Household
  • Hospitals
  • Clinics

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Others
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Others
  • LAMEA
    • Japan
    • China
    • Australia
    • India
    • Others

KEY PLAYERS

  • The Female Health Company
  • Teva Pharmaceutical Industries Limited
  • Allergan plc
  • Bayer AG
  • Pfizer, Inc.
  • The Cooper Companies Inc.
  • Ansell LTD.
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Church & Dwight, Co., Inc.

Other players in the value chain include (profiles not included in the report)

  • Reckitt Benckiser Plc
  • Warner Chilcott Company
  • BioSante Pharmaceuticals Inc.
  •  Agile Therapeutics Inc.
  • HLL Lifecare Limited
  • MANKIND Pharmaceuticals
  • TTK HealthCare
  • Boehringer Ingelheim GmbH
  • Watson Pharmaceuticals, Inc.
  • V-Care Pharma Pvt. Ltd.
  • Vardhman Life care pvt. Ltd.
  • Cipla Limited.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

U.S. NPWT Devices Market - Opportunities and Forecast, 2015 - 2020

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Asian Chromatography Solvents Market - Opportunities and Forecasts, 2015 - 2020

Chromatography is a technique used for separation of mixtures for advanced use. Chromatography solvents, such as methanol, chloroform, ethanol, and others are used for separation of mixtures. One component solvent ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Intra-Dialytic Hypotension (IDH) Asia-Pacific Market Research Report, 2013 - 2020

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ≥20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

European Dermatology Diagnostic Devices Market- Opportunities and Forecasts, 2014 - 2020

The healthcare sector across Europe is witnessing a dramatic shift and is inclined towards less invasive diagnostic procedures. Dermatology diagnostic equipment aids in both easy as well as painless diagnosis. ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>